Annual Current Ratio
17.54
+2.24+14.64%
31 December 2023
Summary:
CRISPR Therapeutics AG annual current ratio is currently 17.54, with the most recent change of +2.24 (+14.64%) on 31 December 2023. During the last 3 years, it has fallen by -0.67 (-3.68%). CRSP annual current ratio is now -13.04% below its all-time high of 20.17, reached on 31 December 2021.CRSP Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Ratio
21.64
+5.91+37.57%
30 September 2024
Summary:
CRISPR Therapeutics AG quarterly current ratio is currently 21.64, with the most recent change of +5.91 (+37.57%) on 30 September 2024. Over the past year, it has increased by +5.81 (+36.70%). CRSP quarterly current ratio is now -17.50% below its all-time high of 26.23, reached on 30 June 2021.CRSP Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRSP Current Ratio Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +14.6% | +36.7% |
3 y3 years | -3.7% | -17.3% |
5 y5 years | +4.3% | +160.1% |
CRSP Current Ratio High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -13.0% | +14.6% | -17.3% | +68.9% |
5 y | 5 years | -13.0% | +14.6% | -17.5% | +160.1% |
alltime | all time | -13.0% | +3797.8% | -17.5% | +628.6% |
CRISPR Therapeutics AG Current Ratio History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | 21.64(+37.6%) |
June 2024 | - | 15.73(-11.7%) |
Mar 2024 | - | 17.81(+1.5%) |
Dec 2023 | 17.54(+14.6%) | 17.54(+10.8%) |
Sept 2023 | - | 15.83(+13.1%) |
June 2023 | - | 14.00(+7.7%) |
Mar 2023 | - | 13.00(-15.0%) |
Dec 2022 | 15.30(-24.1%) | 15.30(+19.4%) |
Sept 2022 | - | 12.81(-27.1%) |
June 2022 | - | 17.57(-11.6%) |
Mar 2022 | - | 19.88(-1.4%) |
Dec 2021 | 20.17(+10.8%) | 20.17(-23.0%) |
Sept 2021 | - | 26.18(-0.2%) |
June 2021 | - | 26.23(+19.0%) |
Mar 2021 | - | 22.05(+21.1%) |
Dec 2020 | 18.21 | 18.21(+10.2%) |
Sept 2020 | - | 16.53(+27.5%) |
June 2020 | - | 12.96(-23.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2020 | - | 16.87(-2.4%) |
Dec 2019 | 17.29(+2.9%) | 17.29(+107.8%) |
Sept 2019 | - | 8.32(-40.4%) |
June 2019 | - | 13.96(-11.9%) |
Mar 2019 | - | 15.84(-5.8%) |
Dec 2018 | 16.81(-1.8%) | 16.81(+9.2%) |
Sept 2018 | - | 15.39(-14.0%) |
June 2018 | - | 17.89(-26.7%) |
Mar 2018 | - | 24.42(+42.6%) |
Dec 2017 | 17.12(+17.6%) | 17.12(-19.8%) |
Sept 2017 | - | 21.34(+20.0%) |
June 2017 | - | 17.79(+1.5%) |
Mar 2017 | - | 17.53(+20.4%) |
Dec 2016 | 14.56(-5.7%) | 14.56(+390.2%) |
Sept 2016 | - | 2.97(-3.9%) |
June 2016 | - | 3.09(-80.0%) |
Dec 2015 | 15.44(+3331.1%) | 15.44 |
Dec 2014 | 0.45 | - |
FAQ
- What is CRISPR Therapeutics AG annual current ratio?
- What is the all time high annual current ratio for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual current ratio year-on-year change?
- What is CRISPR Therapeutics AG quarterly current ratio?
- What is the all time high quarterly current ratio for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly current ratio year-on-year change?
What is CRISPR Therapeutics AG annual current ratio?
The current annual current ratio of CRSP is 17.54
What is the all time high annual current ratio for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual current ratio is 20.17
What is CRISPR Therapeutics AG annual current ratio year-on-year change?
Over the past year, CRSP annual current ratio has changed by +2.24 (+14.64%)
What is CRISPR Therapeutics AG quarterly current ratio?
The current quarterly current ratio of CRSP is 21.64
What is the all time high quarterly current ratio for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly current ratio is 26.23
What is CRISPR Therapeutics AG quarterly current ratio year-on-year change?
Over the past year, CRSP quarterly current ratio has changed by +5.81 (+36.70%)